![Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer - The ASCO Post Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer - The ASCO Post](https://ascopost.com/media/14001996/710-3_image.jpg)
Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer - The ASCO Post
![Maiden to mental- “there's no side effects of taking Letrozole long term.” Idk about you all, but these all seem fairly scary to me. : r/peestickgals Maiden to mental- “there's no side effects of taking Letrozole long term.” Idk about you all, but these all seem fairly scary to me. : r/peestickgals](https://preview.redd.it/maiden-to-mental-theres-no-side-effects-of-taking-letrozole-v0-3wm82582bgq91.jpg?auto=webp&s=77cb5e14d017e9564927952c1b1a67bc86ec71e6)
Maiden to mental- “there's no side effects of taking Letrozole long term.” Idk about you all, but these all seem fairly scary to me. : r/peestickgals
![Frontiers | Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty Frontiers | Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty](https://www.frontiersin.org/files/Articles/906852/fendo-13-906852-HTML/image_m/fendo-13-906852-g001.jpg)
Frontiers | Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty
![Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial - The Lancet Oncology Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/49eb3bdf-e0df-4a9f-b5f2-51f115cb9c81/gr1.jpg)
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial - The Lancet Oncology
![Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review | The BMJ Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review | The BMJ](https://www.bmj.com/content/bmj/363/bmj.k3845/F1.medium.jpg)